Nordea Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $727M | Buy |
5,260,363
+121,664
| +2% | +$17M | 0.68% | 30 |
|
|
2025
Q4 | $630M | Buy |
5,138,699
+726,101
| +16% | +$88.2M | 0.54% | 31 |
|
|
2025
Q3 | $494M | Buy |
4,412,598
+455,665
| +12% | +$51.8M | 0.43% | 48 |
|
|
2025
Q2 | $437M | Buy |
3,956,933
+1,126,886
| +40% | +$120M | 0.41% | 60 |
|
|
2025
Q1 | $317M | Buy |
2,830,047
+2,059,177
| +267% | +$212M | 0.33% | 82 |
|
|
2024
Q4 | $71.1M | Buy |
770,870
+45,507
| +6% | +$4.1M | 0.07% | 226 |
|
|
2024
Q3 | $61M | Sell |
725,363
-261,854
| -27% | -$20M | 0.07% | 237 |
|
|
2024
Q2 | $67.9M | Sell |
987,217
-48,708
| -5% | -$3.25M | 0.08% | 235 |
|
|
2024
Q1 | $76.2M | Sell |
1,035,925
-87,815
| -8% | -$6.75M | 0.09% | 225 |
|
|
2023
Q4 | $91.1M | Buy |
1,123,740
+385,630
| +52% | +$30M | 0.12% | 188 |
|
|
2023
Q3 | $55.8M | Sell |
738,110
-13,003
| -2% | -$1M | 0.08% | 224 |
|
|
2023
Q2 | $57.5M | Sell |
751,113
-45,330
| -6% | -$3.62M | 0.08% | 220 |
|
|
2023
Q1 | $65.1M | Sell |
796,443
-16,785
| -2% | -$1.39M | 0.1% | 197 |
|
|
2022
Q4 | $69.4M | Sell |
813,228
-76,969
| -9% | -$6.1M | 0.11% | 190 |
|
|
2022
Q3 | $56.2M | Sell |
890,197
-109,308
| -11% | -$6.89M | 0.09% | 201 |
|
|
2022
Q2 | $61.6M | Sell |
999,505
-98,320
| -9% | -$6.09M | 0.09% | 198 |
|
|
2022
Q1 | $65.7M | Sell |
1,097,825
-41,082
| -4% | -$2.63M | 0.08% | 212 |
|
|
2021
Q4 | $83.4M | Buy |
1,138,907
+63,845
| +6% | +$4.4M | 0.1% | 201 |
|
|
2021
Q3 | $76.4M | Buy |
1,075,062
+1,012
| +0.1% | +$71.1K | 0.1% | 201 |
|
|
2021
Q2 | $74M | Buy |
1,074,050
+1,166
| +0.1% | +$77.9K | 0.1% | 203 |
|
|
2021
Q1 | $69.4M | Sell |
1,072,884
-203,610
| -16% | -$13.1M | 0.1% | 198 |
|
|
2020
Q4 | $74.4M | Sell |
1,276,494
-14,807
| -1% | -$893K | 0.12% | 178 |
|
|
2020
Q3 | $80.7M | Sell |
1,291,301
-455,341
| -26% | -$31.6M | 0.15% | 145 |
|
|
2020
Q2 | $132M | Buy |
1,746,642
+887,810
| +103% | +$68M | 0.14% | 147 |
|
|
2020
Q1 | $64.2M | Sell |
858,832
-29,666
| -3% | -$2.05M | 0.15% | 130 |
|
|
2019
Q4 | $57.3M | Sell |
888,498
-9,537
| -1% | -$621K | 0.11% | 174 |
|
|
2019
Q3 | $56.9M | Sell |
898,035
-4,693
| -0.5% | -$307K | 0.12% | 159 |
|
|
2019
Q2 | $61M | Sell |
902,728
-193,043
| -18% | -$12.7M | 0.14% | 151 |
|
|
2019
Q1 | $71.2M | Buy |
1,095,771
+69,597
| +7% | +$4.63M | 0.15% | 137 |
|
|
2018
Q4 | $64.2M | Buy |
1,026,174
+127,140
| +14% | +$8.89M | 0.15% | 126 |
|
|
2018
Q3 | $69.4M | Sell |
899,034
-19,018
| -2% | -$1.44M | 0.14% | 123 |
|
|
2018
Q2 | $65M | Sell |
918,052
-3,202
| -0.3% | -$226K | 0.16% | 113 |
|
|
2018
Q1 | $69.5M | Sell |
921,254
-14,628
| -2% | -$1.16M | 0.17% | 114 |
|
|
2017
Q4 | $67M | Sell |
935,882
-259,583
| -22% | -$19.7M | 0.16% | 116 |
|
|
2017
Q3 | $96.9M | Buy |
1,195,465
+205,250
| +21% | +$15.7M | 0.23% | 95 |
|
|
2017
Q2 | $70.1M | Sell |
990,215
-722,386
| -42% | -$48.1M | 0.18% | 114 |
|
|
2017
Q1 | $116M | Sell |
1,712,601
-711,076
| -29% | -$50M | 0.31% | 77 |
|
|
2016
Q4 | $174M | Sell |
2,423,677
-6,576
| -0.3% | -$489K | 0.46% | 54 |
|
|
2016
Q3 | $192M | Buy |
2,430,253
+73,904
| +3% | +$6M | 0.5% | 51 |
|
|
2016
Q2 | $197M | Sell |
2,356,349
-63,962
| -3% | -$5.68M | 0.55% | 46 |
|
|
2016
Q1 | $222M | Buy |
2,420,311
+413,849
| +21% | +$37.3M | 0.67% | 41 |
|
|
2015
Q4 | $203M | Buy |
2,006,462
+99,087
| +5% | +$10.3M | 0.69% | 40 |
|
|
2015
Q3 | $187M | Buy |
1,907,375
+62,536
| +3% | +$6.95M | 0.69% | 41 |
|
|
2015
Q2 | $216M | Buy |
1,844,839
+63,704
| +4% | +$6.96M | 0.76% | 38 |
|
|
2015
Q1 | $175M | Sell |
1,781,135
-6,590
| -0.4% | -$669K | 0.63% | 48 |
|
|
2014
Q4 | $169M | Buy |
1,787,725
+678,739
| +61% | +$70.2M | 0.62% | 50 |
|
|
2014
Q3 | $118M | Buy |
1,108,986
+6,236
| +0.6% | +$611K | 0.47% | 57 |
|
|
2014
Q2 | $91.4M | Sell |
1,102,750
-6,668
| -0.6% | -$519K | 0.38% | 74 |
|
|
2014
Q1 | $78.6M | Buy |
1,109,418
+15,515
| +1% | +$1.22M | 0.37% | 70 |
|
|
2013
Q4 | $82.2M | Sell |
1,093,903
-80,498
| -7% | -$5.61M | 0.41% | 63 |
|
|
2013
Q3 | $73.8M | Sell |
1,174,401
-183,767
| -14% | -$11M | 0.41% | 60 |
|
|
2013
Q2 | $69.6M | Buy |
+1,358,168
| New | +$70.8M | 0.43% | 63 |
|
Other funds holding GILD
VCM
VPM
Nordea Investment Management's GILD Position: Q1 2026 in Review
Nordea Investment Management increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, buying an estimated $17M and bringing the position to 5,260,363 shares worth $727M. The position accounts for 0.68% of the portfolio, ranked #30.
Nordea Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Nordea Investment Management held 5,260,363 shares of Gilead Sciences worth $727M as of Q1 2026.
- Nordea Investment Management bought 121,664 Gilead Sciences shares in Q1 2026, an estimated $17M.
- Gilead Sciences made up 0.68% of Nordea Investment Management's portfolio in Q1 2026, its #30 holding.
- Nordea Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.